Levocetirizine Dihydrochloride Tablet
Product Images NDC 72789-023

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 72789-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789023)

Label for Levocetirizine Dihydrochloride 5 mg tablets, 30 count, from PD-Rx Pharmaceuticals, Inc. The label includes the NDC number 72789-023-30 and states that each tablet contains 5 mg of Levocetirizine Dihydrochloride. It features warnings about drowsiness and instructions to keep out of reach of children, along with lot number 120B66 and expiration date 02/2022.*

FDA Label Image

Levocitirizinestructure (Levocitirizinestructure)

Chemical structure of Levocetirizine Dihydrochloride, showing the molecular arrangement including chlorine-substituted aromatic rings, a piperazine ring, and functional groups corresponding to the dihydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.